Immunocore (NASDAQ:IMCR) Research Coverage Started at Robert W. Baird

Robert W. Baird began coverage on shares of Immunocore (NASDAQ:IMCR – Free Report) in a research report released on Tuesday, Marketbeat Ratings reports. The brokerage issued an outperform rating and a $84.00 price target on the stock. A number of other research firms have also commented on IMCR. Canaccord Genuity Group began coverage on Immunocore […]

Leave a Reply

Your email address will not be published.

Previous post Block (NYSE:SQ) Coverage Initiated at Wells Fargo & Company
Next post Clearwater Paper (NYSE:CLW) Lowered to “Sector Perform” at Royal Bank of Canada